Cargando…
Personalized treatment for hepatocellular carcinoma in the era of targeted medicine and bioengineering
Hepatocellular carcinoma (HCC) is a major global health burden, causing approximately 8.3 million deaths each year, and it is the third leading cause of cancer-related death worldwide, with a relative 5-year survival rate of around 18%. Due to the advanced stage of diagnosis in most patients, system...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198383/ https://www.ncbi.nlm.nih.gov/pubmed/37214451 http://dx.doi.org/10.3389/fphar.2023.1150151 |